BAY3547922 / Bayer - LARVOL DELTA

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer (clinicaltrials.gov) - P1 | N=148 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting

Enrollment open • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer (clinicaltrials.gov) - P1 | N=148 | Not yet recruiting | Sponsor: Bayer

New P1 trial • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

BANTAM-01: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer (clinicaltrials.gov) - P1 | N=148 | Recruiting | Sponsor: Bayer | Trial completion date: Dec 2033 ➔ Aug 2031 | Trial primary completion date: Jul 2030 ➔ Jul 2029

First-in-human • Trial completion date • Trial primary completion date • Hepatocellular Cancer • Liver Cancer • Oncology • Solid Tumor • GPC3

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer (clinicaltrials.gov) - P1 | N=148 | Not yet recruiting | Sponsor: Bayer | Trial completion date: Feb 2029 ➔ Dec 2033 | Trial primary completion date: Nov 2027 ➔ Jul 2030

Trial completion date • Trial primary completion date • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers (clinicaltrials.gov) - P1 | N=14 | Completed | Sponsor: Bayer | Active, not recruiting ➔ Completed

Trial completion • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers (clinicaltrials.gov) - P1 | N=14 | Active, not recruiting | Sponsor: Bayer | Recruiting ➔ Active, not recruiting

Enrollment closed • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers (clinicaltrials.gov) - P1 | N=17 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting

Enrollment open • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer (clinicaltrials.gov) - P1 | N=17 | Not yet recruiting | Sponsor: Bayer | Trial completion date: Aug 2024 ➔ Nov 2024 | Trial primary completion date: Aug 2024 ➔ Nov 2024

Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer (clinicaltrials.gov) - P1 | N=17 | Not yet recruiting | Sponsor: Bayer

New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor